Brief: Rosetta Genomics announces pricing of $5 million concurrent registered direct and private placement offering
23/11/2016 20:35
Nov 23 (Reuters) - Rosetta Genomics Ltd ROSG.O -
* Entered into definitive agreements with one institutional
healthcare investor to purchase an aggregate of 1.1 million
ordinary shares
* Entered into definitive agreements to purchase up to 10
million ordinary shares in a concurrent private placement
* Rosetta Genomics announces pricing of $5 million
concurrent registered direct and private placement offering
Source text for Eikon: ID:nBwb5xRWpa
Further company coverage: ROSG.O
((bangalore.newsroom@thomsonreuters.com;))
Recent news on Rosetta Genomics
See all newsBrief: Interpace Diagnostics Acquires Select Assets Of Rosetta Genomics Out Of Bankruptcy
Brief: Stockholders Approve Genoptix Acquisition Of Rosetta Genomics
Brief: Rosetta Genomics Announces Shareholder Approval Of Merger With Genoptix
Brief: Sabby Management Buys 105,361 ADR Shares Of Rosetta Genomics
Brief: Genoptix Announces Termination Of Merger Agreement With Rosetta Genomics